Thermo Fisher Scientific, Inc. (TMO)
654.80
+2.29
(+0.35%)
USD |
NYSE |
Oct 02, 16:00
654.96
+0.16
(+0.02%)
After-Hours: 20:00
Thermo Fisher Scientific Enterprise Value : 280.71B for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 280.71B |
| October 01, 2026 | 279.87B |
| September 30, 2026 | 288.20B |
| September 29, 2026 | 289.89B |
| September 28, 2026 | 289.51B |
| September 25, 2026 | 288.18B |
| September 24, 2026 | 289.43B |
| September 23, 2026 | 284.59B |
| September 22, 2026 | 282.09B |
| September 21, 2026 | 282.18B |
| September 18, 2026 | 279.47B |
| September 17, 2026 | 282.01B |
| September 16, 2026 | 278.36B |
| September 15, 2026 | 275.75B |
| September 14, 2026 | 265.49B |
| September 11, 2026 | 264.08B |
| September 10, 2026 | 261.63B |
| September 09, 2026 | 262.55B |
| September 08, 2026 | 261.57B |
| September 04, 2026 | 265.55B |
| September 03, 2026 | 267.26B |
| September 02, 2026 | 263.61B |
| September 01, 2026 | 260.64B |
| August 31, 2026 | 266.77B |
| August 28, 2026 | 268.65B |
| Date | Value |
|---|---|
| August 27, 2026 | 271.80B |
| August 26, 2026 | 272.91B |
| August 25, 2026 | 270.86B |
| August 24, 2026 | 271.08B |
| August 21, 2026 | 271.27B |
| August 20, 2026 | 270.64B |
| August 19, 2026 | 265.46B |
| August 18, 2026 | 256.40B |
| August 17, 2026 | 255.09B |
| August 14, 2026 | 256.12B |
| August 13, 2026 | 258.93B |
| August 12, 2026 | 261.56B |
| August 11, 2026 | 262.30B |
| August 10, 2026 | 260.34B |
| August 07, 2026 | 258.23B |
| August 06, 2026 | 253.06B |
| August 05, 2026 | 252.25B |
| August 04, 2026 | 247.42B |
| August 03, 2026 | 250.85B |
| July 31, 2026 | 250.95B |
| July 30, 2026 | 251.86B |
| July 29, 2026 | 251.75B |
| July 28, 2026 | 251.73B |
| July 27, 2026 | 245.49B |
| July 24, 2026 | 248.71B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Agilent Technologies, Inc. | 49.50B |
| Danaher Corp. | 173.98B |
| Illumina, Inc. | 42.59B |
| Bio-Rad Laboratories, Inc. | 9.620B |
| Revvity, Inc. | 19.23B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 1.742B |
| Revenue (Quarterly) | 11.99B |
| Total Expenses (Quarterly) | 10.26B |
| EPS Diluted (Quarterly) | 4.679 |
| Gross Profit Margin (Quarterly) | 40.94% |
| Profit Margin (Quarterly) | 14.52% |
| Earnings Yield | 2.84% |
| Operating Earnings Yield | 3.60% |
| Normalized Earnings Yield | 2.923 |